These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9590143)

  • 1. Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis.
    Adams PC
    Am J Hematol; 1998 May; 58(1):16-9. PubMed ID: 9590143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy.
    Adams PC; Kertesz AE; Valberg LS
    J Clin Gastroenterol; 1993 Apr; 16(3):207-10. PubMed ID: 8505491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
    Adams PC; Chakrabarti S
    Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and phenotypic expression of hemochromatosis in Canadians.
    Borwein ST; Ghent CN; Flanagan PR; Chamberlain MJ; Valberg LS
    Clin Invest Med; 1983; 6(3):171-9. PubMed ID: 6652983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection.
    Le Gac G; Scotet V; Gourlaouen I; L'Hostis C; Merour MC; Karim Z; Deugnier Y; Bardou-Jacquet E; Lefebvre T; Assari S; Ferec C
    Aliment Pharmacol Ther; 2022 Apr; 55(8):1016-1027. PubMed ID: 35122291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education and Imaging: Hepatobiliary and pancreatic: venesection for hemochromatosis.
    Yap P; Hunt R; Das D
    J Gastroenterol Hepatol; 2011 May; 26(5):934. PubMed ID: 21488950
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of hemochromatosis. Hemochromatosis Management Working Group.
    Barton JC; McDonnell SM; Adams PC; Brissot P; Powell LW; Edwards CQ; Cook JD; Kowdley KV
    Ann Intern Med; 1998 Dec; 129(11):932-9. PubMed ID: 9867745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease.
    Beutler E; Felitti V; Ho NJ; Gelbart T
    Acta Haematol; 2002; 107(3):145-9. PubMed ID: 11978935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index.
    Summers KM; Halliday JW; Powell LW
    Hepatology; 1990 Jul; 12(1):20-5. PubMed ID: 2373481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis.
    Hayashi H; Piperno A; Tomosugi N; Hayashi K; Kimura F; Wakusawa S; Yano M; Tatsumi Y; Hattori A; Pelucchi S; Katano Y; Goto H
    Intern Med; 2010; 49(22):2371-7. PubMed ID: 21088336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton EH; Acton RT
    BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
    Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A farewell to phlebotomy-use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report.
    Hamada Y; Hirano E; Sugimoto K; Hanada K; Kaku T; Manda N; Tsuchida K
    J Med Case Rep; 2022 Jan; 16(1):26. PubMed ID: 35065677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening.
    Whiting PW; Fletcher LM; Dixon JK; Gochee P; Powell LW; Crawford DH
    J Hepatol; 2002 Sep; 37(3):309-14. PubMed ID: 12175625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status.
    Chow LH; Frei JV; Hodsman AB; Valberg LS
    Gastroenterology; 1985 Apr; 88(4):865-9. PubMed ID: 3838288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.